ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

RGLS Company Profile and Key Details

NASDAQ : RGLS

Regulus Therapeutics Inc.

$1.80

-0.16-8.16%

At Close 4:00 PM

61.05

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

RGLS Stock Price Chart

Stock Price Today

Regulus Therapeutics Inc. (RGLS) stock declined over -8.16%, trading at $1.80 on NASDAQ, down from the previous close of $1.96. The stock opened at $1.81, fluctuating between $1.73 and $1.95 in the recent session.

Stock Snapshot

1.96

Prev. Close

1.81

Open

119.24M

Market Cap

66.24M

Number of Shares

1.73

Day Low

1.95

Day High

-2.2

P/E Ratio

80.29%

Free Float in %

-0.82

EPS (TTM)

1.05

Book Value

-1.35

Cash Flow per Share

779.01K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 03, 2025	1.81	1.95	1.73	1.80	778.86K
Apr 02, 2025	1.71	2.01	1.67	1.96	1.25M
Apr 01, 2025	1.71	2.05	1.67	1.75	2.58M
Mar 31, 2025	1.74	1.84	1.66	1.75	1.7M
Mar 28, 2025	1.50	1.75	1.48	1.73	2.82M
Mar 27, 2025	1.42	2.05	1.34	1.50	32.53M
Mar 26, 2025	1.33	1.34	1.27	1.29	212.85K
Mar 25, 2025	1.31	1.42	1.30	1.30	380.02K
Mar 24, 2025	1.44	1.47	1.40	1.44	178.25K
Mar 21, 2025	1.37	1.40	1.35	1.37	264.6K
Mar 20, 2025	1.41	1.44	1.32	1.36	109.23K
Mar 19, 2025	1.36	1.43	1.35	1.40	94.8K
Mar 18, 2025	1.37	1.45	1.32	1.38	163.27K
Mar 17, 2025	1.48	1.52	1.36	1.37	148.52K
Mar 14, 2025	1.37	1.56	1.35	1.48	245.4K
Mar 13, 2025	1.42	1.50	1.35	1.38	193.06K
Mar 12, 2025	1.34	1.49	1.30	1.48	2.2M
Mar 11, 2025	1.34	1.39	1.31	1.33	408.8K
Mar 10, 2025	1.30	1.36	1.30	1.33	172.29K
Mar 07, 2025	1.34	1.37	1.28	1.29	126.8K

Contact Details

San Diego, CA 92121

United States

Website: https://www.regulusrx.comContact: 858 202 6300

About Company

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current Regulus Therapeutics Inc. (RGLS) stock price?

Regulus Therapeutics Inc. (NASDAQ: RGLS) stock price is $1.80 in the last trading session. During the trading session, RGLS stock reached the peak price of $1.95 while $1.73 was the lowest point it dropped to. The percentage change in RGLS stock occurred in the recent session was -8.16% while the dollar amount for the price change in RGLS stock was -$0.16.

RGLS's industry and sector of operation?

The NASDAQ listed RGLS is part of Biotechnology industry that operates in the broader Healthcare sector. Regulus Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RGLS?

Mr. Joseph P. Hagan M.B.A.
Chief Executive Officer & Director
Mr. Firuz Shakoori
Head of CMC
Dr. Claire Susan Padgett M.S., M.T., Ph.D.
Senior Vice President of Clinical Operations
Dr. Rekha Garg M.D., M.S.
Senior Vice President of Clinical Devel. & Regulatory
Dr. Denis Drygin Ph.D.
Chief Scientific Officer
Ms. Crispina Calsada CPA
Chief Financial Officer
Mr. Daniel J. Penksa
Executive Director of Fin. & Controller
Mr. Christopher Ray Aker J.D.
Senior Vice President, Gen. Counsel & Corporation Sec.
Dr. Preston S. Klassen M.D., M.H.S.
Pres and Head of R&D

How RGLS did perform over past 52-week?

RGLS's closing price is 116.87% higher than its 52-week low of $0.83 where as its distance from 52-week high of $2.90 is -37.93%.

How many employees does RGLS have?

Number of RGLS employees currently stands at 34.

Link for RGLS official website?

Official Website of RGLS is: https://www.regulusrx.com

How do I contact RGLS?

RGLS could be contacted at phone 858 202 6300 and can also be accessed through its website. RGLS operates from 4224 Campus Point Court, San Diego, CA 92121, United States.

How many shares of RGLS are traded daily?

RGLS stock volume for the day was 779.01K shares. The average number of RGLS shares traded daily for last 3 months was 1.14M.

What is the market cap of RGLS currently?

The market value of RGLS currently stands at $119.24M with its latest stock price at $1.80 and 66.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	34
Beta	1.41
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology